Biocompatible Polyhydroxyethylaspartamide-based Micelles with Gadolinium for MRI Contrast Agents

Area of Science:

• Biomedical Engineering
• Materials Science
• Radiology

Background:

• Development of advanced contrast agents is crucial for improving magnetic resonance imaging (MRI) efficacy.
• Gadolinium-based contrast agents (GBCAs) are widely used but face challenges regarding stability and biocompatibility.
• Novel amphiphilic polymers offer potential for creating safer and more effective MRI contrast agents.

Purpose of the Study:

• To synthesize and characterize a novel amphiphilic micellar contrast agent for MRI.
• To evaluate the performance of the synthesized agent in terms of relaxivity and in vivo imaging.
• To compare the efficacy of the novel agent against a commercial gadolinium contrast agent.

Main Methods:

• Synthesis of PHEA-mPEG-C(16)-ED-DOTA-Gd via conjugation of DOTA-Gd with PHEA-mPEG-C(16) using ethylenediamine.
• Characterization of synthesized materials using proton nuclear magnetic resonance ((1)H NMR).
• Analysis of micelle size and shape using dynamic light scattering (DLS) and atomic force microscopy (AFM).
• Evaluation of relaxivity and in vivo liver imaging in rabbits.

Main Results:

• Successful synthesis of amphiphilic PHEA-mPEG-C(16)-ED-DOTA-Gd micelles.
• Micelles exhibited higher relaxivities compared to a commercial gadolinium contrast agent.
• Effective enhancement of rabbit liver signal intensity following intravenous administration.

Conclusions:

• The synthesized PHEA-mPEG-C(16)-ED-DOTA-Gd micellar system represents a promising MRI contrast agent.
• The agent demonstrates superior relaxivity and effective in vivo imaging capabilities.
• This novel material holds potential for advancing diagnostic imaging applications.